Source link : https://www.newshealth.biz/health-news/tau-blood-test-flags-preclinical-alzheimers-disease/
Plasma phosphorylated (p)-tau217 testing can help identify preclinical Alzheimer’s disease (AD), which could aid clinical trial recruitment. Recruiting preclinical AD participants for clinical research is challenging owing to a lack of symptoms and the high cost and invasiveness of cerebrospinal fluid (CSF) tests and brain amyloid PET imaging. Plasma p-tau217 has consistently shown high performance […]
Author : News Health
Publish date : 2024-07-30 11:28:09
Copyright for syndicated content belongs to the linked Source.